ESMO Asia 2021 – Tackling Uncommon EGFR Mutations
Watch Dr. Satoru Miura as he shares evidence-based approach in individualising
treatment to tackle uncommon EGFR mutations in NSCLC patients
Speaker: Dr. Satoru Miura
Document ID: PC-SG-101316
Speaker
Dr. Satoru Miura
Chief Physician,
Niigata Cancer Center Hospital,
Niigata, Japan
ESMO Asia 2021 – The Role of EGFR-TKIs in the Treatment of Squamous NSCLC
Speaker: Prof. Chung-Yu Chen
ESMO Asia 2021 – A Strategic Approach to Select and Sequence Therapies in EGFRm+ NSCLC
Speaker: Prof. Zhou Caicun
